Stroke genomics in people of African ancestry: Charting new paths

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2015, Pages S39-S47

  Akinyemi, R O ^a,h   Ovbiagele, B ^b   Akpalu, A ^c   Jenkins, C ^k   Sagoe, K ^c   Owolabi, L ^d   Sarfo, F ^e   Obiako, R ^f   Gebreziabher, M ^b   Melikam, E ^i,j   Warth, S ^b   Arulogun, O ^i,j   Lackland, D ^b   Ogunniyi, A ^i,j   Tiwari, H ^g   Kalaria, R N ^h   Arnett, D ^g   Owolabi, M O ^i,j  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF GHANA   (Ghana)

^d BAYERO UNIVERSITY   (Nigeria)

^e KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^f AHMADU BELLO UNIVERSITY   (Nigeria)

^g MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF IBADAN   (Nigeria)

^k NONE

more..

Author keywords

Africa; African ancestry; Cerebrovascular risk factors; Genetics; Genomics; Ghana; Nigeria; Stroke

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; PHOSPHODIESTERASE IV;

AFRICAN AMERICAN; ARTICLE; BLACK PERSON; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FAMILY HISTORY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEALTH DISPARITY; HEREDITY; HERITABILITY; HUMAN; HUMAN GENETICS; HUMAN GENOME; META ANALYSIS (TOPIC); MONOGENIC DISORDER; MULTICENTER STUDY (TOPIC); PHENOTYPE; RISK FACTOR; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW (TOPIC); UNITED STATES; AFRICA; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; STROKE;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; RISK FACTORS; STROKE;

EID: 84930016337     PISSN: 19951892     EISSN: 16800745     Source Type: Journal    
DOI: 10.5830/CVJA-2015-039     Document Type: Article

References (117)

1. Lanktree MB, Dichgans M, Hegele RA, Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 2010; 41(4): 825-832.
2. Bevan S, Markus HS. Genetics of common polygenic ischaemic stroke: current understanding and future challenges. Stroke Res Treat 2011; 2011: 179061.
3. Cole JW, Stine OC, Liu X, Pratap A, Cheng Y, Tallon LJ, et al. Rare variants in ischemic stroke: an exome pilot study. PLoS One 2012; 7(4): e35591.
4. Markus HS. Stroke genetics. Hum Mol Genet 2011; 20(R2): R124-131.
5. Cole JW, Brown DW, Giles WH, Stine OC, O'Connell JR, Mitchell BD, et al. Ischemic stroke risk, smoking, and the genetics of inflammation in a biracial population: the stroke prevention in young women study. Thromb J 2008; 6: 11.
6. Grewal RP, Dutra AV, Liao YC, Juo SH, Papamitsakis NI. The intron 4c allele of the NOS3 gene is associated with ischemic stroke in African Americans. BMC Med Genet 2007; 8: 76.
7. Song Q, Cole JW, O'Connell JR, Stine OC, Gallagher M, Giles WH, et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet 2006; 15(16): 2468-2478.
8. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, Froment A, et al. The genetic structure and history of Africans and African Americans. Science 2009; 324(5930): 1035-1044.
9. Shriner D, Tekola-Ayele F, Adeyemo A, Rotimi CN. Genome-wide genotype and sequence-based reconstruction of the 140,000 year history of modern human ancestry. Sci Rep 2014; 4: 6055.
10. Gurdasani D, Arstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I, Hatzikotoulas K, et al. The African Genome Variation Project shapes medical genetics in Africa. Nature 2015; 517(7534): 327-332.
11. H3Africa Consortium. Research capacity. Enabling the genomic revolution in Africa. Science 2014; 344(6190): 1346-138.
12. Owolabi MO, Mensah GA, Kimmel PL, Adu D, Ramsay M, Waddy SP, et al. Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and tools. Cardiovasc J Afr 2014; 25(3): 134-136.
13. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol 2007; 6(12): 1106-1114.
14. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8(4): 355-69.
15. Owolabi MO. Taming the burgeoning stroke epidemic in Africa: stroke quadrangle to the rescue. West Indian Med J 2011; 60(4): 412-421.
16. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367(9524): 1747-1757.
17. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah G A, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383(9913): 245-254.
18. Moran A, Forouzanfar M, Sampson U, Chugh S, Feigin V, Mensah G. The epidemiology of cardiovascular diseases in sub-Saharan Africa: the Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Prog Cardiovasc Dis 2013; 56(3): 234-239.
19. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104(22): 2746-2753.
20. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104(23): 2855-2864.
21. Khedr EM, et al. Epidemiological study and risk factors of stroke in Assiut Governorate, Egypt: community-based study. Neuroepidemiology 2013; 40(4): 288-294.
22. Akinyemi RO, Izzeldin IM, Dotchin C, Gray WK, Adeniji O, Seidi OA, et al. Contribution of noncommunicable diseases to medical admissions of elderly adults in Africa: a prospective, cross-sectional study in Nigeria, Sudan, and Tanzania. J Am Geriatr Soc 2014; 62(8): 1460-1466.
23. Owolabi LF, Shehu MY, Shehu MN, Fadare J. Pattern of neurological admissions in the tropics: Experience at Kano, Northwestern Nigeria. Ann Indian Acad Neurol 2010; 13(3): 167-170.
24. Akinyemi RO, Allan L, Owolabi MO, Akinyemi JO, Ogbole G, Ajani A et al. Profile and determinants of vascular cognitive impairment in African stroke survivors: The CogFAST Nigeria Study. J Neurol Sci 2014; 346(1-2): 241-249.
25. Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria RN. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. Curr Alzheimer Res 2013; 10(6): 642-53.
26. Owolabi MO. Impact of stroke on health-related quality of life in diverse cultures: the Berlin-Ibadan multicenter international study. Health Qual Life Outcomes 2011; 9: 81.
27. O'Donnell MJ. Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376(9735): 112-123.
28. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLoS One 2014; 9(8): e104300.
29. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM, Rhodes JD, et al. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol 2011; 69(4): 619-627.
30. Gutierrez J, Williams OA. A decade of racial and ethnic stroke disparities in the United States. Neurology 2014; 82(12): 1080-1082.
31. Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010. Stroke 2013; 44(1): 138-145.
32. Rotimi CN, Jorde LB. Ancestry and disease in the age of genomic medicine. N Engl J Med 2010; 363(16): 1551-1558.
33. Saab KR, Kendrick J, Yracheta JM, Lanaspa MA, Pollard M, Johnson RJ. New insights on the risk for cardiovascular disease in African Americans: The role of added sugars. J Am Soc Nephrol 2015; 26(2): 247-257.
34. Burchard EG, Ziv E, Coyle N, Gomez SL,Tang H, Karter AJ, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003; 348(12): 1170-1175.
35. Collins FS. What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat Genet 2004; 36(Suppl 11): S13-15.
36. Cooper RS, Kaufman JS, Ward R, Race and genomics. N Engl J Med 2003; 348(12): 1166-1170.
37. Adeyemo AA, Chen G, Chen Y, Rotimi C. Genetic structure in four West African population groups. BMC Genet 2005. 6: 38.
38. Ramsay M, Tiemessen CT, Choudhury A, Soodyall H. Africa: the next frontier for human disease gene discovery? Hum Mol Genet 2011; 20(R2): R214-220.
39. Gomez F, Hirbo J, Tishkoff SA. Genetic variation and adaptation in Africa: implications for human evolution and disease. Cold Spring Harb Perspect Biol 2014; 6(7): a008524.
40. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449(7164): 851-861.
41. Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491(7422): 56-65.
42. Graffe CC, Bech JN, Lauridsen TG, Vase H, Pedersen EB. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension. BMC Nephrol 2012; 13: 15.
43. Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 2013; 45(4): 440-4, 444e1-2.
44. Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, Williams S, et al. Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci USA 2010; 107(2): 786-791.
45. Bryc K, Durand EY, Macpherson JM, Reich D, Mountain JL. The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States. Am J Hum Genet 2015; 96(1): 37-53.
46. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007; 6(2): 149-161.
47. Morrison AC, Fornage M, Liao D, Boerwinkle E. Parental history of stroke predicts subclinical but not clinical stroke: the Atherosclerosis Risk in Communities Study. Stroke 2000; 31(9): 2098-2102.
48. Liao D, Myers R, Hunt S, Shahar E, Paton C, Burke G, et al. Familial history of stroke and stroke risk. The Family Heart Study. Stroke 1997; 28(10): 1908-1912.
49. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35(1): 212-227.
50. Minor DS, Wofford MR, Jones DW. Racial and ethnic differences in hypertension. Curr Atheroscler Rep 2008; 10(2): 121-127.
51. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5(7): e1000564.
52. Reder NP, Tayo BO, Salako B, Ogunniyi A, Adeyemo A, Rotimi C, et al. Adrenergic alpha-1 pathway is associated with hypertension among Nigerians in a pathway-focused analysis. PLoS One 2012; 7(5): e37145.
53. Rice T, Cooper RS, Wu X, Bouchard C, Rankinen T, Rao DC, et al. Meta-analysis of genome-wide scans for blood pressure in African American and Nigerian samples. The National Heart, Lung, and Blood Institute GeneLink Project. Am J Hypertens 2006; 19(3): 270-274.
54. Sorensen IF, Vazquez AI, Irvin MR, Sorensen P, Davis BR, Ford CE, et al. Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study. Pharmacogenet Genomics 2014; 24(11): 556-563.
55. Adeleye JO, Abbiyesuku FM. Glucose and insulin responses in offspring of Nigerian Type 2 diabetics. Afr J Med Med Sci 2002; 31(3): 253-257.
56. Mbanya JC, Pani LN, Mbanya DN, Sobngwi E, Ngogang J, et al. Reduced insulin secretion in offspring of African type 2 diabetic parents. Diabetes Care 2000; 23(12): 1761-1765.
57. Tekola-Ayele F, Adeyemo AA, Rotimi CN. Genetic epidemiology of type 2 diabetes and cardiovascular diseases in Africa. Prog Cardiovasc Dis 2013; 56(3): 251-260.
58. Chen G, Adeyemo A, Zhou J, Chen Y, Huang H, Doumatey A, et al. Genome-wide search for susceptibility genes to type 2 diabetes in West Africans: potential role of C-peptide. Diabetes Res Clin Pract 2007; 78(3): e1-6.
59. Ovbiagele B. Impairment in glomerular filtration rate or glomerular filtration barrier and occurrence of stroke. Arch Neurol 2008; 65(7): 934-938.
60. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40(10): 1175-1184.
61. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329(5993): 841-845.
62. Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA, Ogunniyi A, et al. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. Int Urol Nephrol 2013; 45(2): 485-494.
63. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, et al. Missense mutations in the APOL1 gene are highly associated with end-stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128(3): 345-350.
64. Bentley AR, Doumatey AP, Chen G, Huang H, Zhou J, Shriner D, et al. Variation in APOL1 Contributes to Ancestry-Level Differences in HDLc-Kidney Function Association. Int J Nephrol 2012; 2012: 748984.
65. Van der Sijde MR, Ng A, Fu J. Systems genetics: From GWAS to disease pathways. Biochim Biophys Acta 2014; 1842(10): 1903-1909.
66. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A, D'Agostino RB, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004; 35(7): 1609-1613.
67. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke 2005; 36(1): 5-8. Epub 2004 Nov 29.
68. Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med 2009; 122(6): 507-512.
69. Piel FB, atil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010; 1: 104.
70. Lemos Cardoso G, Farias Guerreiro J. African gene flow to north Brazil as revealed by HBB∗S gene haplotype analysis. Am J Hum Biol 006; 18(1): 93-98.
71. Osuntokun BO, Osuntokun O. Complicated migraine and haemoglobin AS in Nigerians. Br Med J 1972; 2(5814): 621-622.
72. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91(1): 288-294.
73. Flanagan JM, Frohlich DM, Howard TA, Schultz WH, Driscoll C, Nagasubramanian R, et al. Genetic predictors for stroke in children with sickle cell anemia. Blood 2011; 117(24): 6681-6684.
74. Flanagan JM, heehan V, Linder H, Howard TA, Wang YD, Hoppe CC, et al. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood 2013; 121(16): 3237-3245.
75. Ruchoux MM, Maurage CA. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997; 56(9): 947-964.
76. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol 2011; 37(1): 94-113.
77. Lee SJ, Meng H, Elmadhoun O, Blaivas M, Wang MM. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy affecting an African American man: identification of a novel 15-base pair NOTCH3 duplication. Arch Neurol 2011; 68(12): 1584-1586.
78. Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic stroke. Nat Rev Neurol 2011; 7(7): 369-378.
79. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, et al. Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 1998;. 7(12): 1851-1858.
80. Janunger T, Nilsson-Ardnor S, Wiklund PG, Lindgren P, Escher SA, Lackovic K, et al. A novel stroke locus identified in a northern Sweden pedigree: linkage to chromosome 9q31-33. Neurology 2009; 73(21): 1767-1773.
81. Nilsson-Ardnor S, Janunger T, Wiklund PG, Lackovic K, Nilsson AK, Lindgren P, et al. Genome-wide linkage scan of common stroke in families from northern Sweden. Stroke 2007; 38(1): 34-40.
82. Wang XY, Wang JW, Tang X, Li N, Chen DF, Wu YQ, et al. Linkage and association between interleukin-6 gene polymorphisms and ischemic stroke: a family-based study in the northern Chinese Han population. Genet Test Mol Biomarkers 2014; 18(11): 761-766.
83. Liu B, Zhang L, Yang Q. Genetics of intracerebral hemorrhage: Insights from candidate gene approaches. Neurol India 2012; 60(1): 3-8.
84. Biffi A, Anderson CD, Jagiella JM, Schmidt H, Kissela B, Hansen BM, et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 2011; 10(8): 702-709.
85. Brouwers HB, Biffi A, Ayres AM, Schwab K, Cortellini L, Romero JM, et al. Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke 2012; 43(6): 1490-1495.
86. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148(6): 2083-2095.
87. Kalaria RN, Ogeng'o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM, et al. Evaluation of risk factors for Alzheimer's disease in elderly east Africans. Brain Res Bull 1997; 44(5): 573-577.
88. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 2005; 36(9): 2027-2031. Epub 2005 Jul 28.
89. Meschia JF. Stroke genome-wide association studies: the large numbers imperative. Stroke 2010; 41(4): 579-580.
90. Markus HS, Alberts MJ. Update on genetics of stroke and cerebrovascular disease 2005. Stroke 2006; 37(2): 288-290. Epub 2006 Jan 12.
91. Meschia JF, Nalls M, Matarin M, Brott TG, Brown RD Jr, Hardy J, et al. Siblings with ischemic stroke study: results of a genome-wide scan for stroke loci. Stroke 2011; 42(10): 2726-2732.
92. Hata J, Kubo M, Kiyohara Y. [Genome-wide association study for ischemic stroke based on the Hisayama study]. Nihon Eiseigaku Zasshi 2011; 66(1): 47-52.
93. Matarin M, Brown WM, Dena H, Britton A, De Vrieze FW, Brott TG, et al. Candidate gene polymorphisms for ischemic stroke. Stroke 2009; 40(11): 3436-3442.
94. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 2008; 64(4): 402-409.
95. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009; 41(8): 876-878.
96. Bilguvar K, Yasuno K, Niemelä M, Ruigrok YM, von Und Zu Fraunberg M, van Duijn CM, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008; 40(12): 1472-1477.
97. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genome-wide association studies of stroke. N Engl J Med 2009; 360(17): 1718-1728.
98. Yamada Y, Fuku N, Tanaka M, Aoyagi Y, Sawabe M, Metoki N, et al. Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 2009; 207(1): 144-149.
99. Zhang W, Chen Y, Liu P, Chen J, Song L, Tang Y, et al. Variants on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population. Stroke 2012; 43(1): 14-21.
100. Matsushita T, Ashikawa K, Yonemoto K, Hirakawa Y, Hata J, Amitani H, et al. Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke. Hum Mol Genet 2010; 19(6): 1137-1146.
101. International Stroke Genetics Consortium (ISGC); Wellcome Trust Case-Control Consortium 2 (WTCCC2), Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012; 44(3): 328-333.
102. Holliday EG, Maguire JM, Evans TJ, Koblar SA, Jannes J, Sturm JW, et al. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet 2012; 44(10): 1147-1151.
103. Zhang Y, Tong Y, Zhang Y, Ding H, Zhang H, Geng Y, et al. Two novel susceptibility SNPs for ischemic stroke using exome sequencing in Chinese Han population. Mol Neurobiol 2014; 49(2): 852-862.
104. Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. J Stroke Cerebrovasc Dis 2007; 16(4): 153-9.
105. Saidi S, Slamia LB, Ammou SB, Mahjoub T, Almawi WY. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J Stroke Cerebrovasc Dis 2007; 16(4): 160-166.
106. Saidi S, Mahjoub T, Slamia LB, Ammou SB, Al-Subaie AM, Almawi WY. Association of human platelet alloantigen 1 through 5 polymorphisms with ischemic stroke. Cerebrovasc Dis 2008; 25(1-2): 81-86.
107. Saidi S, Mahjoub T, Slamia LB, Ammou SB, Al-Subaie AM, Almawi WY. Polymorphisms of the human platelet alloantigens HPA-1, HPA-2, HPA-3, and HPA-4 in ischemic stroke. Am J Hematol 2008; 83(7): 570-573.
108. Saidi S, Zammiti W, Slamia LB, Ammou SB, Almawi WY, Mahjoub T. Interaction of angiotensin-converting enzyme and apolipoprotein E gene polymorphisms in ischemic stroke involving large-vessel disease. J Thromb Thrombol 27(1): 68-74. Epub 2007 Nov 21.
109. Saidi S, Mallat SG, Almawi WY, Mahjoub T. Association between renin-angiotensin-aldosterone system genotypes and haplotypes and risk of ischemic stroke of atherosclerotic etiology. Acta Neurol Scand 2009. 119(6): 356-363.
110. Saidi S, Mallat SG, Almawi WY, Mahjoub T. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene polymorphisms and the risk of ischemic stroke. Acta Neurol Scand 2010; 121(2): 114-119.
111. Saidi S, Mahjoub T, Almawi WY. Aldosterone synthase gene (CYP11B2) promoter polymorphism as a risk factor for ischaemic stroke in Tunisian Arabs. J Renin Angiotensin Aldosterone Syst 11(3): 180-186.
112. Mourad H, Fadel W, El Batch M, Rowisha M. Heamostatic and genetic predisposing factors for stroke in children with sickle cell anemia. Egypt J Immunol 2008; 15(1): 25-37.
113. Marshall PA, Adebamowo CA, Adeyemo AA, Ogundiran TO, Strenski T, Zhou J, et al. Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria. BMC Med Ethics 2014; 15: 38.
114. Olaitan PB, Odesina V, Odesina V, Ademola S, Fadiora SO, Oluwatosin OM, Reichenberger EJ. Recruitment of Yoruba families from Nigeria for genetic research: experience from a multisite keloid study. BMC Med Ethics 2014; 15: 65.
115. Fagbemiro L, Adebamowo C. Knowledge and attitudes to personal genomics testing for complex diseases among Nigerians. BMC Med Ethics 2014; 15: 34.
116. Howard G, Wagenknecht LE, Kernan WN, Cushman M, Thacker EL, Judd SE, et al. Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke 2014; 45(8): 2257-2262.
117. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 2005; 25(3): 135-143.